These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20594569)

  • 21. Tick-Borne Encephalitis Virus Nonstructural Protein NS5 Induces RANTES Expression Dependent on the RNA-Dependent RNA Polymerase Activity.
    Zheng Z; Yang J; Jiang X; Liu Y; Zhang X; Li M; Zhang M; Fu M; Hu K; Wang H; Luo MH; Gong P; Hu Q
    J Immunol; 2018 Jul; 201(1):53-68. PubMed ID: 29760190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A critical determinant of neurological disease associated with highly pathogenic tick-borne flavivirus in mice.
    Yoshii K; Sunden Y; Yokozawa K; Igarashi M; Kariwa H; Holbrook MR; Takashima I
    J Virol; 2014 May; 88(10):5406-20. PubMed ID: 24574402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis.
    Mandl CW
    Virus Res; 2005 Aug; 111(2):161-74. PubMed ID: 15871909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.
    Pletnev AG; Swayne DE; Speicher J; Rumyantsev AA; Murphy BR
    Vaccine; 2006 Sep; 24(40-41):6392-404. PubMed ID: 16831498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice.
    Eyer L; Nougairède A; Uhlířová M; Driouich JS; Zouharová D; Valdés JJ; Haviernik J; Gould EA; De Clercq E; de Lamballerie X; Ruzek D
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31142664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of tick-borne encephalitis virus isolated from a tick in central Hokkaido in 2017.
    Takahashi Y; Kobayashi S; Ishizuka M; Hirano M; Muto M; Nishiyama S; Kariwa H; Yoshii K
    J Gen Virol; 2020 May; 101(5):497-509. PubMed ID: 32134377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates.
    Maximova OA; Ward JM; Asher DM; St Claire M; Finneyfrock BW; Speicher JM; Murphy BR; Pletnev AG
    J Virol; 2008 Jun; 82(11):5255-68. PubMed ID: 18353947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the poly(A) tract in the replication and virulence of tick-borne encephalitis virus.
    Asghar N; Lee YP; Nilsson E; Lindqvist R; Melik W; Kröger A; Överby AK; Johansson M
    Sci Rep; 2016 Dec; 6():39265. PubMed ID: 27982069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells.
    Blaney JE; Manipon GG; Firestone CY; Johnson DH; Hanson CT; Murphy BR; Whitehead SS
    Vaccine; 2003 Oct; 21(27-30):4317-27. PubMed ID: 14505914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in mice.
    Lee HC; Yen YT; Chen WY; Wu-Hsieh BA; Wu SC
    PLoS One; 2011; 6(10):e25800. PubMed ID: 22053180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus.
    Timofeev AV; Butenko VM; Stephenson JR
    Virus Genes; 2004 Jan; 28(1):85-97. PubMed ID: 14739654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tick-borne encephalitis virus strains of Western Siberia.
    Bakhvalova VN; Rar VA; Tkachev SE; Matveev VA; Matveev LE; Karavanov AS; Dobrotvorsky AK; Morozova OV
    Virus Res; 2000 Sep; 70(1-2):1-12. PubMed ID: 11074120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial Characterization of Tick-Borne Encephalitis Virus Isolates from Ticks of Southern Ukraine.
    Yurchenko OO; Dubina DO; Vynograd NO; Gonzalez JP
    Vector Borne Zoonotic Dis; 2017 Aug; 17(8):550-557. PubMed ID: 28654319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes.
    Hanley KA; Lee JJ; Blaney JE; Murphy BR; Whitehead SS
    J Virol; 2002 Jan; 76(2):525-31. PubMed ID: 11752143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness.
    Goto A; Hayasaka D; Yoshii K; Mizutani T; Kariwa H; Takashima I
    Vaccine; 2003 Sep; 21(25-26):4043-51. PubMed ID: 12922141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and biological properties of yellow fever 17D/dengue type 1 recombinant virus.
    Mateu GP; Marchevsky RS; Liprandi F; Bonaldo MC; Coutinho ES; Dieudonné M; Caride E; Jabor AV; Freire MS; Galler R
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):289-98. PubMed ID: 17169387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
    Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
    Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of tick-borne encephalitis virus using large-scale random codon re-encoding.
    de Fabritus L; Nougairède A; Aubry F; Gould EA; de Lamballerie X
    PLoS Pathog; 2015 Mar; 11(3):e1004738. PubMed ID: 25734338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.